Skip to main content

  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2C - The Prevalence of Hyperkalemia and Associated Clinical Characteristics and Outcomes Among Hospitalized COVID-19 Patients
    Location: L-2
    Health Economics/Outcomes Research
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2J - Cost-utility of Nivolumab for Treatment of Head and Neck Cancer from a Brazilian Public Health System Perspective
    Location: L-2
    Health Economics/Outcomes Research
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2K - SGLT2 Inhibitors vs. GLP-1 Agonists: Comparative Progression of Renal Disease
    Location: L-2
    Health Economics/Outcomes Research
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2L - Comparison of Medication Adherence Between Initiators of a Multi-drug Dispensing System & Users of Retail Pharmacy
    Location: L-2
    Health Economics/Outcomes Research
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2M - Effects of Initiating a Multi-dose Drug Dispensing System on Medication Adherence
    Location: L-2
    Health Economics/Outcomes Research
  • Tuesday, Aug 24th
    1:45 PM - 3:30 PM US Eastern Time
    OP-25A - Comparative Risk of Hospitalization for Heart Failure Among Patients with Xanthine Oxidase Inhibitors and Uricosuric Agents
    Location: OP-25
    Health Economics/Outcomes Research
  • Tuesday, Aug 24th
    3:30 PM - 4:45 PM US Eastern Time
    SP0K - Impact of Lipid Lowering Therapy Modifications on Medication Adherence in Older Adults
    Location: SP01
    Health Economics/Outcomes Research
  • Tuesday, Aug 24th
    3:30 PM - 4:45 PM US Eastern Time
    SP03H - Direct Health Care Costs Among Patients with Rheumatoid Arthritis Before and After the Initiation of Treatment with Jaki in Tuscany: The LEONARDO Study
    Location: SP03
    Health Economics/Outcomes Research
  • Tuesday, Aug 24th
    3:30 PM - 4:45 PM US Eastern Time
    SP05A - Outcomes in Patients (pts) with Advanced Basal Cell Carcinoma (aBCC) Who Discontinued First-line (1L) Hedgehog Inhibitors (HHI) Systemic Treatment (Tx) in a US Community Oncology Setting: A Retrospective Observational Study
    Location: SP05
    Health Economics/Outcomes Research
  • Tuesday, Aug 24th
    3:30 PM - 4:45 PM US Eastern Time
    SP05F - DNA Mismatch Repair and Microsatellite Instability in Colorectal Tumors: An Observational Study in the Veterans Affairs Health Care System
    Location: SP05
    Health Economics/Outcomes Research
  • Tuesday, Aug 24th
    5:15 PM - 6:30 PM US Eastern Time
    SP13B - Real-world Safety and Efficacy of Same-day Discharge After Catheter Ablation for Atrial Fibrillation
    Location: SP13
    Health Economics/Outcomes Research
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-10D - Impact of Race, Ethnicity, and Sex on Treatment of Non-valvular Atrial Fibrillation
    Location: OP-10
    Health Economics/Outcomes Research
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-12A - Participant Engagement and Adherence in an Arthritispower Real-world Study to Capture Smartwatch and Patient-reported Outcome Data Among Rheumatoid Arthritis Patients
    Location: OP-12
    Health Economics/Outcomes Research
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-12C - The Friends of Cancer Research Real World Data (RWD) Pilot 2.0 Collaboration: Implementation of Standardized Methodological Approaches for Evaluation of Oncology RWD
    Location: OP-12
    Health Economics/Outcomes Research
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-12D - Cost-effectiveness of Systematic Treatments for Metastatic Castration-sensitive Prostate Cancer: An Economic Evaluation Based on Network Meta-analysis
    Location: OP-12
    Health Economics/Outcomes Research
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-12E - Telemedicine Use Among U.S. Patients with Cancer During the COVID-19 Pandemic
    Location: OP-12
    Health Economics/Outcomes Research